KunduSD.FeldmanDR.CarverBSet al. Rates of teratoma and viable cancer at post-chemotherapy retroperitoneal lymph node dissection after induction chemotherapy for good risk nonseminomatous germ cell tumors. J Urol. 2015;193(2):513-518.doi:10.1016/j.juro.2014.08.081http://www.ncbi.nlm.nih.gov/pubmed/25150639
2.
ChagantiRS.HouldsworthJ. Genetics and biology of adult human male germ cell tumors. Cancer Res. 2000;60(6):1475-4482.http://www.ncbi.nlm.nih.gov/pubmed/10749107
3.
OldenburgJ.AlfsenGC.LienHHet al. Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses. J Clin Oncol. 2003;21(17):3310-3317.doi:10.1200/JCO.2003.03.184http://www.ncbi.nlm.nih.gov/pubmed/12947067